TITLE

Percutaneous Autologous Bone Marrow-Derived Mesenchymal Stromal Cell Implantation Is Safe for Reconstruction of Human Lower Limb Long Bone Atrophic Nonunion

AUTHOR(S)
Emadedin, Mohsen; Labibzadeh, Narges; Fazeli, Roghayeh; Mohseni, Fatemeh; Hosseini, Seyedeh Esmat; Moghadasali, Reza; Mardpour, Soura; Azimian, Vajiheh; Goodarzi, Alireza; Liastani, Maede Ghorbani; Bafghi, Ali Mirazimi; Eslaminejad, Mohamadreza Baghaban; Aghdami, Nasser
PUB. DATE
April 2017
SOURCE
Cell Journal (Yakhteh);Spring2017, Vol. 19 Issue 1, p159
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objective: Nonunion is defined as a minimum of a 9-month period of time since an injury with no visibly progressive signs of healing for 3 months. Recent studies show that application of mesenchymal stromal cells (MSCs) in the laboratory setting is effective for bone regeneration. Animal studies have shown that MSCs can be used to treat nonunions. For the first time in an Iranian population, the present study investigated the safety of MSC implantation to treat human lower limb long bone nonunion. Materials and Methods: It is a prospective clinical trial for evaluating the safety of using autologus bone marrow derived mesenchymal stromal cells for treating nonunion. Orthopedic surgeons evaluated 12 patients with lower limb long bone nonunion for participation in this study. From these, 5 complied with the eligibility criteria and received MSCs. Under fluoroscopic guidance, patients received a one-time implantation of 20-50×106 MSCs into the nonunion site. All patients were followed by anterior-posterior and lateral X-rays from the affected limb, in addition to hematological, biochemical, and serological laboratory tests obtained before and 1, 3, 6, and 12 months after the implantation. Possible adverse effects that included local or systemic, serious or non-serious, and related or unrelated effects were recorded during this time period. Results: From a safety perspective, all patients tolerated the MSCs implantation during the 12 months of the trial. Three patients had evidence of bony union based on the after implantation X- rays. Conclusion: The results have suggested that implantation of bone marrow-derived MSCs is a safe treatment for nonunion. A double-blind, controlled clinical trial is required to assess the efficacy of this treatment (Registration Number: NCT01206179).
ACCESSION #
120788300

 

Related Articles

  • Are cultured mesenchymal stromal cells an option for immunomodulation in transplantation? Plock, Jan A.; Schnider, Jonas T.; Schweizer, Riccardo; Gorantla, Vijay S.; Bondanza, Attilio; Biagi, Ettore // Frontiers in Immunology;Feb2013, Vol. 4, Special section p1 

    The article discusses a study by E. Eggenhofer and colleagues published in an issue of "Frontiers in Immunology" on the role of cultured mesenchymal stromal cells (MSCs) in immunomodulation in transplantation. The researchers presented evidence in a mouse model that cultured bone-marrow derived...

  • Regulatory pathways associated with bone loss and bone marrow adiposity caused by aging, chemotherapy, glucocorticoid therapy and radiotherapy. Georgiou, Kristen R.; Hui, Susanta K.; Xian, Cory J. // American Journal of Stem Cells;2012, Vol. 1 Issue 3, p205 

    The bone marrow is a complex environment that houses haematopoietic and mesenchymal cell populations and regulates bone turnover throughout life. The high proliferative capacity of these cell populations however, makes them susceptible to damage and injury, altering the steady-state of the bone...

  • Mesenchymal stem cells derived from vertebrae (vMSCs) show best biological properties. Barbanti Brodano, Giovanni; Terzi, Silvia; Trombi, Luisa; Griffoni, Cristiana; Valtieri, Mauro; Boriani, Stefano; Magli, Maria Cristina // European Spine Journal;Nov2013 Supplement 6, Vol. 22, p979 

    Purpose: Due to their properties and characteristics human mesenchymal stem cells (MSCs) appear to have great therapeutic potential. Many different populations of MSCs have been described and to understand whether they have equivalent biological properties is a critical issue for their...

  • Hydrodynamic loading in concomitance with exogenous cytokine stimulation modulates differentiation of bovine mesenchymal stem cells towards osteochondral lineages. Goldman, Stephen M.; Barabino, Gilda A. // BMC Biotechnology;2/1/2016, Vol. 16, p1 

    Background: Mesenchymal stem cells (MSCs) are viewed as a having significant potential for tissue engineering and regenerative medicine therapies. Clinical implementation of MSCs, however, demands that their preparation be stable and reproducible. Given that environmental and bioprocessing...

  • Effect of bone marrow-derived stem cells on chondrocytes from patients with osteoarthritis. QIANGZHI ZHANG; YONG CHEN; QIANG WANG; CHAOYONG FANG; YU SUN; TAO YUAN; YUEBEI WANG; RONGNI BAO; NINGJIAN ZHAO // Molecular Medicine Reports;2016, Vol. 13 Issue 2, p1795 

    Increasing numbers of individuals are suffering from osteoarthritis every year, and the directed intra-articular injection of bone marrow stem cells has provided a promising treatment strategy for osteoarthritis. Although a number of studies have demonstrated that intra-articular injection of...

  • STEM CELLS. JAVIDAN, ARSHIA // Meducator;Dec2015, Issue 28, p6 

    The article reports a study by biomedical engineers at Tufts University which demonstrated that human mesenchymal stem cells (hMSCs) from bone marrow can be a potential treatment for spinal cord injury.

  • Blocking Nox2 improves mesenchymal stem cells therapy in myocardial infarction via antagonizing oxidant and promoting survival. Feng, Dan; Zhang, Lai; Ding, Fengzhi; Yang, Fan; Ma, Wenya; Han, Zhenbo; Hua, Bingjie; Wang, Xiuxiu; Yu, Ying; Huang, Qi; Lei, Lei; Pan, Zhenwei; Cai, Benzhi // Journal of Cellular Physiology;Oct2018, Vol. 233 Issue 10, p7004 

    An increase in reactive oxygen species (ROS) plays a key role in aging and apoptosis in mesenchymal stem cells derived from bone marrow (BMSCs). NADPH oxidase Nox2 serves as an important source of intracellular ROS formation. This study is designed to determine if blocking Nox2 enhances...

  • Proteomic analysis of the impact of static culturing on the expansion of rat bone marrow mesenchymal stem cells. Peter, Stefan; Evans, Caroline; Ow, Saw; Scutt, Andy; Wright, Phillip; Biggs, Catherine // Biotechnology Letters;Aug2012, Vol. 34 Issue 8, p1589 

    The clinical potential of mesenchymal stem cells (MSC) in tissue engineering and regenerative medicine is due to their self-renewal, proliferation and multi-lineage differentiation potential. Clinical use requires large cell numbers; which can, theoretically, be generated by ex vivo expansion of...

  • Mesenchymal Stromal Cells from Umbilical Cord Blood. Bieback, Karen; Kl�ter, Harald // Current Stem Cell Research & Therapy;Dec2007, Vol. 2 Issue 4, p310 

    Mesenchymal Stromal Cells (MSC) are key candidates for cellular therapies. Although most therapeutic applications have focused on adult bone marrow derived MSC, increasing evidence suggests that MSC are present within a wide range of tissues. Umbilical cord blood (CB) has been proven to be a...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics